Atlantic Health Partners

The MDAFP has a strong resource – Atlantic Health Partners – to help our members successfully address the financial and administrative challenges of providing immunizations to your patients.


The HPV Vaccine: Expanding Its Role in Cancer Prevention

mri ct scan for cervical spine injury of patient.

November 10, 2020 – When the human papilloma virus (HPV) vaccine was first introduced in 2006, the primary purpose was to prevent cervical cancer caused by HPV in pre-teen girls and young women. Since then, the vaccine has proven to serve a broader community and recognized to prevent six types of cancer by the Center for Disease Control and Prevention (CDC).

Most recently, in June 2020, the U.S. Food & Drug Administration (FDA) approved the HPV vaccine, Gardasil 9, to prevent oropharyngeal and other head and neck cancers caused by HPV. Particularly as in-person care visits resume, providers have an opportunity to help patients catch up on preventative care measures they may have missed during the pandemic, including the HPV vaccine. READ MORE


Strengthening Your Vaccine Program to Weather Any Change

October 27, 2020 – While the COVID-19 pandemic has caused wide-ranging disruption across the healthcare industry, primary care practices have faced many additional challenges that impact all aspects of patient care, from diagnosing new conditions to vaccine administration. These changes require handoffs and continuity of care to ensure that patients’ care plans, especially preventative care like immunizations, are maintained.    

Even with disruptions, maintaining preventative health is a key way practices can protect their patient populations, particularly as we enter flu season amidst the ongoing pandemic.  READ MORE


Prevention is the Best Medicine: Making the Flu Vaccine a Part of COVID-19 Precautions this Fall

September 8, 2020 – From observing stay-at-home orders to wearing masks, people have taken numerous steps to protect not only themselves, but also their communities from the spread of COVID-19. Now, the upcoming flu season, which spans from October to May, presents another opportunity for Americans to step up and help keep each other healthy.

While it’s uncertain what effect flu season will have in tandem with the coronavirus pandemic, healthcare professionals can encourage their patients to receive the flu vaccine, as a preventative measure, as we head into the fall.  READ MORE


The Importance of Child and Teen Immunization Amid COVID-19

August 18, 2020 – The return to school each year often serves as a reminder for parents to review their children’s immunization records. While the impact of the COVID-19 pandemic means the start of this school year will look different for many, it does not lessen the importance of children getting vaccinated. In fact, as the virus continues to spread, protecting children against vaccine-preventable diseases is more important than ever. READ MORE


50 is the New 60: Making the Shingles Vaccine a Priority for Patients

July 28, 2020 – Each year, it’s estimated that millions of Americans are affected by shingles, and one in three Americans will have shingles in their lifetime according to the Centers for Disease Control and Prevention (CDC). In 2006 the first shingles vaccine, Zostavax, was approved for use and was more recently replaced by Shingrix as the CDC-recommended vaccine for adults 50 years of age and older.

Despite the prevalence of shingles and development of Shingrix, the CDC reports that only 33.4% of adults 60 years and older have received the shingles vaccine. A CDC study also found that coverage among adults aged 50 to 59 is only around 6%. These low rates of vaccination uptake and age disparities may be attributed to low rates of adult vaccination overall, a misunderstanding of who should receive the vaccine, or lack of awareness of available preventions. The current health risks associated with COVID-19 further emphasize the need for patients to utilize all preventative measures available, including vaccines, to maintain their overall wellbeing.

By educating patients on the effects of shingles and who needs the vaccine, providers can improve shingles vaccine uptake and ensure that their patients are protected against this painful disease.  READ MORE


Promoting Health Through Vaccine Uptake During the COVID-19 Crisis

June 16, 2020 – The COVID-19 pandemic has impacted all facets of the healthcare system, including providers and their patients. Some providers chose to close offices completely, while others rescheduled well visits to future dates. As a result, the Medical Group Management Association (MGMA) reports that practices cite a 60% decrease in patient volume since the start of the COVID-19 crisis.

Now, as providers begin to welcome patients back into their practices, and as patients begin to feel more comfortable returning to the doctor’s office for well visits, there is an opportunity for providers to ensure patients have received the vaccines they need. Given the current health risks associated with the coronavirus, it’s critical that patients have the best defense against vaccine-preventable diseases to maintain their overall health. Below, we highlight several considerations for providers as their patient visits begin to increase.  READ MORE


Developing New Vaccines: From Clinical Trials to Your Practice

May 26, 2020 – Facing the COVID-19 pandemic, scientists and manufacturers are working to develop a new vaccine that will protect against the virus. Though there is urgency surrounding the need for a coronavirus vaccine, there are many steps that go into the research, development, approval and manufacturing of a new vaccine. 

By understanding the vaccine development process, providers can ensure that their patients are well-educated about vaccine development and properly prepare their practices for any new vaccines that become available. READ MORE


ATLANTIC HEALTH PARTNERS EXPANDS ITS PROGRAM TO OFFER ADDITIONAL VACCINE SAVINGS!

Atlantic Health Partners has always been a strong resource for our members’ immunization efforts by offering the most favorable vaccine prices, terms, and purchasing support. We are pleased to share with you that Atlantic has expanded its program with the addition of GlaxoSmithKline (GSK) vaccines.  This include options for practices interested in the GSK portfolio or for those practices just interested in using Bexsero (Meningitis B vaccine). 

Atlantic now offers our members the full array of vaccine options to best meet your individual practice needs including:

  • Most favorable pricing for Sanofi, Merck, GSK, and Dynavax vaccines
  • A comprehensive flu program that includes Sanofi, GSK, and Seqirus products
  • Meningoccocal B vaccine options that include both Trumenba or Bexsero
  • No minimum quantity requirements to always receive most favorable pricing and terms
  • Excellent and timely customer service including reimbursement support and advocacy     

For information about the program please contact Jeff or Cindy at 800-741-2044 or info@atlantichealthpartners.com     

www.atlantichealthpartners.com


Disclaimer: The Maryland Academy of Family Physicians (MDAFP) has entered into a business relationship with Atlantic Health Partners to offer our members discounts and exclusive savings. This or other affinity program relationships presented by the MDAFP in no way implies a MDAFP endorsement of the program, supplier, or vendor.

© Copyright 2020 MDAFP or MDAFP Foundation • 210 Green Bay Rd • Thiensville, WI 53092 • Phone: 888-894-2606 • E-Mail: info@mdafp.org